Arianto S. In silico approach of antiviral compound from Cymbopongon citratus as the main protease SARS-CoV-2 inhibitor. IJMLST [Internet]. 2025 Oct. 30 [cited 2026 Jul. 26];7(2):130-7. Available from: https://journal2.unusa.ac.id/index.php/IJMLST/article/view/5754